Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
Hemasphere
; 6(2): e672, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1722645
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Hemasphere
Year:
2022
Document Type:
Article
Affiliation country:
HS9.0000000000000672
Similar
MEDLINE
...
LILACS
LIS